Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Dyslipidemias

• Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention
• A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia
• Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With Dyslipidemia
• A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(6)
• A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391(2)
• A Study of LY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty Liver Disease (NAFLD)
• Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg
• Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.
• A Multicenter Study to Evaluate the Effect of High Dose Rosuvastatin Versus Rosuvastatin and Ezetimibe in Stroke
• A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities
• A Phase 1 Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamic Effects of VSA003 in Chinese Adult Healthy Volunteers
• High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium
• Phase 3 Trial to Evaluate the Efficacy and Safety of DKP21102_B Added on to DKP21102_A Compared With DKP21102_A
• Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic Men
• A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of Rosuvastatin.
• Effects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus
• A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)
• Effect of Alpelisib in Healthy Volunteers
• Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial
• Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity
• A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(5) 80/20/10mg
• A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391
• Efficacy and Safety of JS002 as Monotherapy in Patients With Primary Hypercholesterolaemia and Mixed Dyslipidemia
• The Safety and Long-Term Clinical Benefit of PCSK9i in STEMI Patients
• Clinical Trial of Crocus Kozanis Administration in Obese Children and Adolescents
• Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-386 in Healthy Volunteers Under Fasting Conditions
• A Phase I Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348
• Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients
• Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
• Randomized Study in Patients With HeFH to Evaluate Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies
• A Dose-Finding Study in Japanese Patients to Evaluate the Effect of Obicetrapib as an Adjunct to Stable Statin Therapy.
• Study of ARO-APOC3 in Adults With Dyslipidemia
• A Study to Evaluate the Efficacy and Safety of AD-218
• A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD0780 in Healthy Subjects
• Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
• Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
• Phase 1 Study to Evaluate the Safety and Pharmacokinetics of CKD-331 in Healthy Adult Volunteers
• To Evaluate the Efficacy and Safety in Patients With Dyslipidemia and Hypertension
• Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy
• A Study of LY3561774 in Participants With Mixed Dyslipidemia
• A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg
• Compare the Impact of Xuezhikang and Atorvastatin on Glucose Metabolism in Dyslipidemia Patients With Prediabetes
• A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3)
• Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies
• Study of ARO-APOC3 in Adults With Mixed Dyslipidemia
• A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg
• A Dose-response Study of Dietary Resveratrol on Lipid Metabolism Disorder
• Effects of Oral Fenofibrate on Retinal Thickness and Macular Volume
• A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2)
• Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP.
• Phase 1 to Evaluate the Safety and Pharmacokinetic Durg-drug Interaction of YYC506-T and YYC506-A
• Phase 1 to Evaluate the Safety and Pharmacokinetic Characteristics of Fixed-dose Combination of YYC506
• Pueraria Lobata and Pueraria Thomsonii for Mild Dyslipidemia
• Effect of Berberine on Metabolic Syndrome, Efficacy and Safety in Combination With Antiretroviral Therapy in PLWH.
• Phase 3 Trial to Evaluate the Efficacy and Safety of YYC506.
• Study of ARO-ANG3 in Adults With Mixed Dyslipidemia
• A Study of AZD8233 in Participants With Dyslipidemia.
• Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507
• Randomized Study of Obicetrapib in Combination With Ezetimibe
• Vildagliptin for Treatment of Antipsychotic-induced Dyslipidemia
• Randomized Study of Obicetrapib as an Adjunct to Statin Therapy
• A Phase III Long Term Study of K-877 Extended Release Tablet
• A Phase III Confirmatory Study of K-877 Extended Release Tablet
• Ezetimibe Utilization Early After Acute Myocardial Infarction, "EzAMI Trial"
• Efficacy and Safety of EzetimiBe/Rosuvastatin in Diabetic Dislipidemia With Hypertriglyceridaemia
• A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2)
• A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386
• A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348
• A Study of LY3561774 in Participants With Dyslipidemia
• Compare the Efficacy and Safety of 1PC111 With Pitavastatin and Ezetimibe in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
• A Study of AZD8233 in Participants With Dyslipidemia
• Efficacy Assessment of Chinese Herbal Medicine Jiangtang Tiaozhi Recipe Treating Participants With Glucose and Lipid Metabolism Disturbances
• Study to Investigate Safety, Tolerability, PK and PD Response of SLN360 in Subjects With Elevated Lipoprotein(a)
• Efficacy and Safety of Berlim 25/10 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia
• Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.
• Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
• A Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348
• A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70)
• Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IR
• Determining the Effect of Vitamin D, Dyslipidemia and Microvascular in Patients With Type 2 Diabetes
• Developing an Obesity Treatment Program in Family Medicine Clinics
• Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet
• Clinical Trial to Evaluate the Efficacy and Safety of CKD-386
• A Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348
• Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451
• To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD8233 After Multiple Dose Administration in Subjects With Dyslipidemia
• Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab (Olmesartan 20 mg/Amlodipine 5 mg/Rosuvastatin 5 or 10 mg) in Hypertension Patients With Low-Intermediate Risk for Cardiovascular Disease
• A Clinical Pharmacology Study of K-877 Controlled Release Tablet
• A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia
• Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia
• A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD6615 in Healthy Subjects
• A Study of LY3475766 in Healthy Participants
• Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy Volunteers
• Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event
• CD24Fc Administration to Decrease Low-Density Lipoprotein (LDL) and Inflammation in Human Immunodeficiency Virus (HIV) Patients (CALIBER) (MK-7110-003)
• Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia
• Clinical Trial to Evaluate Efficacy and Safety of ROVASRO 10mg Versus CRESTOR 10mg in Hypercholesterolemic Patients
• EXpanded Combination of Evolocumab Plus Empagliflozin on Diabetes: EXCEED-BHS3 Trial
• A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Male Volunteers
• Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients With Dyslipidemia
• Vascepa to Accelerate Lipoprotein Uptake and Elimination
• Cinical Trial to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy
• BE Study of Bilayer Combination of Gemigliptin/Rosuvastatin 50/20mg in Comparison to Monolayer Combination.
• The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin
• Compare the Pharmacokinetics and Safety of CKD-333 With Co-administration CKD-330 and D090 in Healthy Male Adults
• Type 2 Diabetic Patients Maintained on Statin Therapy
• Early Alirocumab to Reduce LDL-C in Myocardial Infarction
• Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients
• Effects of Pitavastatin Treatments on the Plasma Lgi3 Level in the Patients With Dyslipidemia
• A Study to Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy Subjects
• Effects of Acute, Rapid Lowering of LDL Cholesterol With Alirocumab in Patients With STEMI Undergoing Primary PCI
• The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers Volunteers
• Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population
• Pharmacokinetics and Safety Profile of CKD-333
• A Clinical Trial to Evaluate the Efficacy and Safety of Pitavastatin/Fenofibrate in Complex-dyslipidemia
• Extended Release Niacin and Fenofibrate for the Treatment of Atherogenic Dyslipidemia in Obese Females
• Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients
• A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects
• Red Rice Yeast in Low-density Lipoprotein (LDL) Lowering: an Efficacy Study
• Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study)
• Clinical Trial to Evaluate the Efficacy and Safety of CKD-333 Tablet
• A Study to Evaluate the Effects of NST-4016 on QT/Corrected QT (QTc) Interval
• Efficacy and Safety of Cipros 20 Association on Dyslipidemia Treatment
• China Protection Trial of Glucose Metabolism by Pitavastatin in Patients With Prediabetes and Hypertension
• Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment
• Evaluate the Efficacy and Safety of KI1106 in Patients Whose TG Level is Not Adequately Controlled With Atorvastatin Calcium Monotherapy While LDL-C is Properly Controlled
• Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease
• Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Participants With Primary Hypercholesterolemia and Mixed Dyslipidemia
• Safety and Efficacy of Statins for Chinese Patients With Dyslipidemia
• Dietary Anthocyanins Improve Lipid Metabolism in a Dose - Dependent Manner
• Efficacy of Fixed-doses of Antihypertensive and Statin Drugs
• A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337
• Effects of Psyllium on Niacin Tolerability
• The Effect of Prednisone on Atherogenesis as Studied in the Macrophage Foam Cell Formation Model System.
• A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337
• A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and Dyslipidemia
• Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension
• Effects of Evolocumab on Platelet Reactivity in Patients With Diabetes Mellitus After Elective Percutaneous Coronary Intervention
• Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension
• Switching TDF/FTC/EFV to TDF/FTC/RPV VS Continuing TDF/FTC/EFV in HIV Patients With Complete Virological Suppression
• The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers Volunteers
• A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between YHR1705 and YHR1706
• Effect of Polyvitaminics (Pyridoxine Hydrochloride, Folic Acid and Cyanocobalamin) in the Concentration of Homocysteine and Lipid Profile in Postmenopausal Women: a Randomized Controlled, Double-blind Clinical Trial
• Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519
• Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and Dyslipidemia
• Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)
• Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects
• Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia
• Vitamin D Supplementation for Treatment of Dyslipidemia
• Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL
• Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Rosuvastatin
• Fourier Open-label Extension Study in Subjects With Clinically Evident Cardiovascular Disease in Selected European Countries
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
• Fixed Combination for Lipid and Blood Pressure Control
• Effect of PCSK9-Antibody (Alirocumab) on Dyslipidemia Secondary to Nephrotic Syndrome
• To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors
• Dyslipidemia of Obesity Intervention in Teens
• A Multi-center, Randomized, Double-blind, Active-controlled, Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia
• Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects
• A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia
• Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers
• Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia
• Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed Dyslipidemia
• Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and Dyslipidemia
• Capsaicin Effect on Cytokines Profile in Dyslipidemia
• Efficacy & Long-term Safety Comparison Study of NK-104-CR & Livalo® IR With Primary Hyperlipidemia or Mixed Dyslipidemia
• Dose-response Study of Carduus Marianus in Centesimal Scale for Dyslipidemia in Climacteric Overweighed or Obese Women.
• Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519
• Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))
• The Efficacy and Safety of Combined Therapy With Red Yeast Rice and Low-dose Statin：Comparing With Standardized Statin
• A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia
• Evaluation of Absorption, Metabolism, and Excretion and Estimation of the Absolute Bioavailability of K-312
• Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia
• Fixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dyslipidemia.
• Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia
• A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337
• Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)
• Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject.
• Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes
• Effect of Administration of the Combination Bezafibrate More Berberine on Lipid Profile in Patients With Dyslipidemia
• Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia
• Bococizumab HIV Evaluation (B-HIVE) Study
• Bioequivalence Study of Capsule and Tablet Formulations of TA-8995
• Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519(CKD-519 FDI)
• Fenofibrate Treatment in SCI
• Effects of Pitavastatin on Lipid Profiles in HIV-infected Patients With Dyslipidemia and Receiving Atazanavir/Ritonavir
• Cilostazol-Simvastatin Drug Interaction Study
• ADME Study in Healthy Male Subjects With TA-8995
• A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.
• Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients
• Effects of Simvastatin and Ezetimibe on Cardiovascular Risk Markers in Patients With Dyslipidemia
• Phase III Study of Rosuvastatin and Fenofibrate Versus Rosuvastatin in Mixed Dyslipidemia
• Study of the Electrocardiographic Effects of TA-8995
• Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
• Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody
• A Study of Evacetrapib in Participants With Abnormal Cholesterol
• A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and Dyslipidemia
• Clinical Trial to Evaluate the Efficacy and Safety of Pravafenix Cap to Verify the Superiority Than Atorvastatin
• Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519
• Characterization of High Density Lipoprotein (HDL) in Type 2 Diabetes (T2D) After Fenofibrate or Niacin Treatment
• Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE)
• The HDL Particle Protection Study
• The Impact of Ezetimibe on Biochemical Markers of Cardiovascular Risk in Kidney Transplant Patients
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
• A Thorough Corrected QT Interval Trial
• CKD-337 Drug Interaction Study
• A Study on Postmarketing Xuezhikang Capsule for Treating Dyslipidemia
• Study on the Efficacy aNd Safety of Jinlida Granules in Patients With Inadequately cOntrolled tYpe-2 Diabetes and dysLIpidemia Under liFe Style Intervention (ENJOY LIFE Study)
• Effect of Vitamin D Supplementation on Exercise Adaptations in Patients on Statin Therapy
• Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe
• Effects of Niacin On Fatty Acid Trapping
• PK Study of Telmisartan/Rosuvastatin FDC Compared to Combination of Telmisartan and Rosuvastatin
• Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
• TA-8995: Its Use in Patients With Mild Dyslipidaemia (TULIP)
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
• Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
• Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia
• Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon Like Peptide 2
• Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular Risk
• Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia
• The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
• Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 After Multiple Doses in Healthy Subjects
• Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 With Single, Escalating Doses in Healthy Subjects
• Characterization of Multi-dose RVX000222 in Combination With Statin Treatment in Dyslipidemia
• Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia
• Metformin for Treatment of Antipsychotic-induced Dyslipidemia
• Intima Media Thickness Regression in Dyslipidemic Teenagers
• Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
• Clinical Study for Patients With Hypertension Associated With Dyslipidemia
• A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese Participants With Dyslipidemia (MK-0859-051 AM1)
• Effects of Metformin on Hepatic FFA Metabolism
• A Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CAT-2003
• Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver Disease
• The Therapeutic Effects of Statins and Berberine on the Hyperlipemia
• The Effect of XueZhiKang on Fatigue：Comparing With Simvastatin
• A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats
• Safety and Pharmacokinetis of TAP311 in Dyslipidemic Patients
• Efficacy and Safety Study of 5 mg and 10 mg Rosuvastatin
• Physiological Study of Human Cholesterol Metabolism and Excretion
• A Study to Evaluate the Efficacy and Safety of Vytorin Versus Standard Treatment of Other Statins in Moderate, Moderately High and High Risk Participants (MK-0653A-406)
• The Effect of Type 2 Diabetes and Dietary Regulation on VLDL1-and VLDL2-triglyceride Metabolism
• Efficacy and Safety of Fluvastatin Sodium Extended Release Tablets 80 mg Once Daily in Chinese Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
• A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipidemia
• Effect of Nigella Sativa on Lipid Profiles in Elderly
• A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
• Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents
• Treatment Effects of Atorvastatin on Hemostasis and Skin Microcirculation in Patients With Type 1 Diabetes
• Treatment on Iatrogenic Weight Gain and Dyslipidaemia Associated With Olanzapine
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAP311 in Healthy Subjects and Dyslipidemic Patients
• Thyroxin Treatment in Sub Clinical Hypothyroidism, on the Apnea Hypopnea Index Score, Lipids and Highly Sensitive CRP
• Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505
• A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With Dyslipidemic
• Trial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1-Infected Subjects With Dyslipidemia And Sustained Viral Load Suppression Under Monotherapy With Ritonavir-Boosted Protease Inhibitors
• Regulation of Intestinal and Hepatic Lipoprotein Secretion by Resveratrol
• Nicotinic Acid Composition of HDL and Arterial Endothelium Function in Premature Coronary Heart Disease and High HDL
• Longitudinal Study of Multi-Analyte Profile for Dyslipidemia
• Study of Lipid Control in Hyperlipidemic Participants (MK-0653-179)
• The Study of Quantitative Serial Trends in Lipids With ApolpoproteinA-I Stimulation
• Efficacy/Safety of Rosuvastatin+Ezetimibe in High Risk Patients With Primary Hypercholesterolemia/Mixed Dyslipidemia
• Niacin/Laropiprant Tablet for South and Southeast Asians With Low High-Density Lipoprotein Cholesterol (LDL-C) at Risk for Cardiovascular Disease (MK-0524A-108)
• Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia
• A Study of LY2484595 in Japanese Subjects
• A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins
• A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins
• Efficacy and Safety of Extended-Release Niacin/ Laropiprant/Simvastatin Tablets in Participants With Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-143)
• Lipid Efficacy of the Extended Release Niacin/Laropiprant Combination in Patients With Cardiovascular Disease
• A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects
• A Study to Evaluate Efficacy and Safety of Extended-Release Niacin + Laropiprant + Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118)
• The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With Hypercholesterolemia
• Effect of Oral L-carnitine Supplement on Lipid Profile, Anemia, and Quality of Life of Patients
• Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (MK-0524A-133)
• Pilot Study With GFT505 (80mg) in Atherogenic Dyslipidaemic Patients With Abdominal Obesity
• A Study to Assess the Efficacy and Safety of ETC-1002 in Subjects With Elevated Blood Cholesterol and Either Normal or Elevated Triglycerides
• Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia
• Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis
• Effect of Niacin/Laropiprant on Postprandial Lipoprotein Metabolism in Patients With Dyslipoproteinemia
• Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy
• Niacin (+) Laropiprant (TREDAPTIVE) Re-examination Study (MK-0524A-119)
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin
• GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II Diabetes
• Metabolic Effects of an 8 Week Niaspan Treatment in Patients With Abdominal Obesity and Mixed Dyslipidemia
• Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia
• Pharmacokinetics of Anacetrapib (MK0859) in Subjects With Impaired Renal Function (MK-0859-038)
• Pharmacokinetics of Anacetrapib (MK0859) in Patients With Hepatic Insufficiency (MK-0859-039)
• Safety Study of BMS-823778 in Subjects With Hypercholesterolemia
• A Study of LY2484595 in Patients With High LDL-C or Low HDL-C
• A Multiple Ascending Dose Study of ETC-1002 in Subjects With Mild Dyslipidemia
• A Study of Niaspan on Endothelium-Dependent and Endothelium-Independent Vascular Reactivity (0000-093)
• The Effects of Hypolipemic and Antidiabetic Treatment on Cytokines
• Effects of Niaspan™ on High-density Lipoprotein (HDL) in Healthy Male Subjects (0000-069)
• Study of A3309 in Patients With Dyslipidemia
• Safety Study of BMS-770767 in Subjects With Hypercholesterolemia
• The Impact of Tredaptive on Flow-Mediated Dilation in Cardiac Patients
• Dyslipidemia in Cardiovascular Disease
• Study of Trilipix Effects on Lipids and Arteries
• Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia
• The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3)
• Study of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol Levels
• Safety Study of BMS-816336 in Healthy Male Subjects
• A Study of Safety and Efficacy of MK0859 (Anacetrapib) in Japanese Patients With Dyslipidemia (0859-029)
• A Long-term Study of ERN/LRPT (Extended Release Niacin/Laropiprant [MK0524A]) in Patients With Dyslipidemia (0524A-102)
• MK0524A Bioequivalence Study (0524A-059)
• MK0524B Bioequivalence Study (0524B-070)
• Lipid Biomarker Study in Men With Dyslipidemia After Simvastatin Treatment (Study MK-0000-140)(COMPLETED)
• Effects of Nateglinide vs Acarbose on Postprandial Glucose Fluctuation, Dyslipidemia, and Inflammatory Factors
• Fenofibrate Bioequivalence Study (0767-031)
• Study to Test GSK256073 in Patients With Dyslipidemia
• Comparison of Pitavastatin With Atorvastatin in Increasing High Density Lipoprotein - Cholesterol (HDL-C) and Adiponectin in Patients With Dyslipidemia and Coronary Artery Disease (CAD)
• Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on Dialysis
• Metabolic and Vascular Effects of Statins in Untreated Dyslipidemic Diabetic Patients
• A Study to Evaluate MK1903 in Patients With Dyslipidemia (MK1903-004)
• Effect of Eggplant Extract on Lipid Profile During Fasting and Postprandial Period
• Effect of Fenofibrate on Sleep Apnea Syndrome
• Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol ("Bad Cholesterol") and Triglycerides
• Repeat Dose Food Effect Study of GSK256073F in Healthy Adult Subjects
• A Study in Healthy Volunteers of Single Doses of Orally Administered Investigational Product to Investigate Safety, Tolerability, and Pharmacokinecs.
• Eprotirome for the Treatment of Dyslipidemia, Efficacy and Safety 12-Week, Phase ii Study to Assess the Safety and Efficacy of KB2115 in Patients With Primary Hypercholesterolemia
• Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.
• Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL Cholesterol
• Efficacy and Safety Study of JTT-302 in Subjects With Low HDL-C Levels
• Safety Study of JTT-302 in Subjects With Low HDL-C Levels
• Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study
• Retrospective Survey Evaluating the Effectiveness and Safety of Dual Inhibition Lipid-lowering in the Treatment of Dyslipidemia (Study P05171)(COMPLETED)
• Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT)
• Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects
• MK0767 in Metabolic Syndrome-Dyslipidemia (0767-016)
• Change in Plaque Characteristics With Atorvastatin
• A Study to Assess the Effect of RO4607381 in Patients With Relatively Low Levels of High Density Lipoprotein-Cholesterol (HDL-C)
• An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
• Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels
• Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) Levels
• 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease
• An Open-Label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin
• ABT-335 (Choline Fenofibrate) Reverse Cholesterol Transport (RCT) Study
• Comparison of Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome
• 12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia
• Extended Release (ER) Niacin/Laropiprant Add on Study (0524A-082)
• Efficacy of Nicotine Acid on Dyslipidaemia in Patients With Metabolic Syndrome
• Begin With The Right Patients With Dual-Inhibition Action Therapy Through Vytorin for Newly Diagnosed Dyslipidemia Patients (0653A-172)(COMPLETED)
• 48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety
• IIIb 6 Week Open Label Multicentre Rosuvastatin & Simvastatin
• Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS)
• Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP)
• Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES)
• Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia (0653-141)(COMPLETED)
• Atorvastatin Study For The Treatment Of High Cholesterol In Patients From Thailand
• A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol
• A Study Of Atorvastatin For The Treatment Of High Cholesterol In Patients At High Risk Of Coronary Heart Disease (CHD)
• A Study Of The Efficacy Of Atorvastatin For Lowering Cholesterol In High-Risk Patients With High Cholesterol
• Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood
• Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin
• Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia
• Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Antipsychotic Drugs in Healthy Humans
• Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Haloperidol in Healthy Humans
• Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
• Fenofibrate and Pharmacogenetic Impact in Dyslipidemia
• A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers
• Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia
• TTA in Treatment of Diabetes and Dyslipidemia
• LDL-Cholesterol Lowering Effect of KB2115 as Add on to Statin
• Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered Concomitantly
• A Second Study to Determine the Effect of GSK256073A on HVTs
• Dyslipidemia in Type 2 Diabetes (0767-034)
• A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia
• Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia
• Lipitor Korean Atorvastatin Goal Achievement Across Risk Levels Study
• Evaluate the Efficacy and Safety of Rosuvastatin Versus Simvastatin in Type 2 Diabetic Patients With Dyslipidemia
• Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia
• ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency
• A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia
• Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and Dyslipidemia
• Study Of Pharmacokinetics and Pharmacodynamics Effects Of GSK256073A On Healthy Volunteers
• Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia
• An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in Subjects With Mixed Dyslipidemia
• Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease in Hemodialysis Patients
• MK-0524B Lipid Study (MK-0524B-063)
• Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067)
• Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia
• Clinical Trial of Zocor (Simvastatin) and Vytorin (Ezetimibe/Simvastatin) in Adolescents With Type 1 Diabetes
• Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia.
• An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)
• A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia
• Efficacy and Safety of Berberine in the Treatment of Diabetes With Dyslipidemia
• Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors
• Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS)
• Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS)
• Effect of Atazanavir on Endothelial Function in HIV-Infected Patients
• Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)
• Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets
• Japanese Study of Rimonabant in Obese Patients With Dyslipidemia (VENUS)
• Effect of Omega -3 Fatty Acids Supplements and Plant Sterol Enriched Food in Dyslipidemic Adults
• Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes
• European Trial About Effect of RimoNabant on Abdominal Obese Patients With dysLipidemia
• A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk
• Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-Dyslipidemia
• The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study
• Regulation of Lipoprotein Metabolism in Obese Men
• An Exploratory Study To Look At The Effect Of Two Investigational Drugs On Body Fat And Inflammation
• Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin
• Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome
• A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia
• Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics Study
• Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO
• Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration
• Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSI
• Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions
• Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes
• Acceptability of a Fixed Combination of Fenofibrate and Metformin
• Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients
• Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care
• Dose-Ranging Study Evaluating AVE1625 in Abdominally Obese Patients With Atherogenic Dyslipidemia
• Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
• Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors
• MK0354 Clinical Efficacy and Tolerability Study (0354-004)
• Caduet in an Untreated Subject Population
• Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia
• Effects of Statin Medications on Mental Processes, Behavior, and Serotonin Levels
• Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
• Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia
• Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia
• Effect of CP-778,875 on HDL-C in Subjects With Abnormal Lipid Levels and Type 2 Diabetes.
• Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
• Effect Of GW501516X On How The Heart Obtains And Uses Energy
• Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia
• Preliminary Study of Safety and Efficacy of Policosanol
• Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin
• Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
• Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin
• Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study
• Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia
• Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood
• Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood
• Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood
• Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.
• Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-lowering Strategy
• The Use of Magnesium to Improve Blood Pressure, Cholesterol, and Glucose Control
• Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia.
• A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol (A5091031).
• A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder.
• A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol.
• Study In Patients With Dyslipidaemia
• Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly Patients
• Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia.
• Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol.
• Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels
• Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia
• A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome
• Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)
• An International Study of Rimonabant in Dyslipidemia With AtheroGenic Risk In Abdominally Obese Patients
• A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With Dyslipidemia
• SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia
• Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects
• Treatment of Insulin Resistance in Hypertensive, Obese Adolescents
• Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.
• Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial Dysfunction
• Efficacy and Safety Study of Fluvastatin and Ezetimibe Combined Versus Fluvastatin Alone
• Trial to Evaluate the Efficacy of Fluvastatin on Certain Markers
• Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia
• Dyslipidemia Study Investigating The Increase In "Good Cholesterol"
• GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol
• Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population
• Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol
• Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia
• Fluvastatin in Adults With Dislipidemia With History of Muscle Problems
• A Study in People With Abnormal Fat Levels in the Blood
• An Investigational Drug Study Evaluating a Novel Approach to Treat Dyslipidemia (0524A-032)
• Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy
• Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST
• Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS)
• Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL
• Obese Patients With Untreated Dyslipidemias